Digital illustration of interacting proteins with a highlighted mutation site.

Decoding Protein Interactions: Can AI Predict Mutation Effects?

"New machine learning model offers a faster, more reliable way to predict how mutations alter protein binding, impacting drug design and personalized medicine."


Proteins are the workhorses of our cells, and their interactions are fundamental to life. When mutations occur in proteins, they can disrupt these interactions, leading to disease. Understanding how mutations affect protein binding is crucial for developing effective therapies, especially for complex conditions like cancer. Traditionally, measuring these effects has been a slow and painstaking process.

Experimental methods for assessing binding affinities, while valuable, are often time-consuming and labor-intensive. This creates a bottleneck, especially with the rapid increase in data on disease-causing mutations generated by modern sequencing technologies. The need for faster, more reliable computational methods to predict the impact of these mutations is greater than ever.

Computational approaches offer a promising alternative, broadly falling into three categories: rigorous methods (like thermodynamic integration), empirical energy-based methods, and machine learning-based methods. Each has its strengths and weaknesses. Machine learning, in particular, is gaining traction for its ability to analyze complex datasets and identify subtle patterns that influence protein interactions.

AI Search Multiple angles on this topic

Why Mutation Effects Matter

Mutations can alter the conformation and thermodynamics of protein–protein interactions, making their functional impact important to quantify. Human disease mutations can affect protein–protein interfaces within a three-dimensional, structurally resolved interaction network. The Human Protein Atlas presents interaction networks using data from IntAct, BioPlex, OpenCell, and BioGRID, including consensus interactions found in more than one dataset.

From Interactomes to Interfaces

The study of protein interactions began slowly and developed through conceptual and technological progress during the late nineteenth and twentieth centuries. Later research examined how protein–protein interactions evolved and how evolutionary information could be used to predict interactions at both the global interactome level and the detailed interface level. Research on protein history has also used ribosomal protein segments to reveal an atomic-level record of protein folding.

How iSEE Predicts Mutation Effects

Digital illustration of interacting proteins with a highlighted mutation site.

A new machine learning model called iSEE (interface Structure, Evolution and Energy-based) is changing the game. iSEE uses a combination of structural, evolutionary, and energy-based features to predict how single-point mutations affect protein binding affinity. Unlike some complex models, iSEE achieves high accuracy with a relatively small number of carefully selected features.

The model was trained on a diverse dataset of over 1,100 mutations in 57 different protein-protein complexes. This extensive training allows iSEE to accurately predict changes in binding affinity, as measured by a Pearson correlation coefficient of 0.80 and a root mean square error of 1.41 kcal/mol.

  • Interface Structure: iSEE considers the 3D structure of the protein complex, focusing on the interface where the proteins interact.
  • Evolution: The model incorporates evolutionary information, leveraging the fact that conserved amino acids are often critical for protein function and binding.
  • Energy: iSEE calculates the energy of the interaction, taking into account factors like van der Waals forces and electrostatic interactions.
AI Search Multiple angles on this topic

AI Models for Mutation Effects

Recent work has applied artificial intelligence to predict changes in protein binding affinity caused by single-point mutations. The 3D-ΔΔG model integrates sequence information with three-dimensional structural information to capture changes before and after mutation. InterDDG, described as a pretraining-based deep learning framework, reported improved performance on a benchmark dataset and an external validation dataset.

Limits of Prediction

Machine-learning predictors remain dependent on the features and structural information available to them. The iSEE predictor uses 31 features, a deliberately small set intended to reduce overfitting, whereas mCSM could use more than 100 features. Recent reviews emphasize that assessing variant effects on protein–protein interactions still faces limitations and unresolved challenges, including the need for mechanistic structural insight to support therapeutic development.

iSEE's success lies in its ability to balance these different types of information. By considering both the physical structure and the evolutionary history of the proteins, the model can make accurate predictions about the impact of mutations.

Looking Ahead: iSEE's Impact on Protein Research

iSEE represents a significant step forward in our ability to understand and predict the effects of mutations on protein interactions. Its speed, accuracy, and reliance on readily available data make it a valuable tool for researchers in a variety of fields, from drug discovery to personalized medicine. As the model continues to be refined and expanded, it promises to unlock new insights into the complex world of protein interactions and their role in human health.

AI Search Multiple angles on this topic

Toward Structure-Aware Prediction

Future research is focusing on computational methods that model protein complexes and predict protein–protein interactions from three-dimensional structures. Recent breakthroughs in structure prediction and the growing volume of genomic sequence data have brought predictions for permanent interactions closer to experimental accuracy, while transient interactions remain an area of promise. Reviews published in 2025 describe artificial intelligence as driving advances in PPI prediction, basic biology, and therapeutics while also highlighting continuing challenges.

iSEE's interface-based mutation predictor

PopulationSingle point mutations at protein–protein complex interfaces[1]
Sample size1102 mutations in 57 protein-protein complexes[1]
ComparisonEight other predictors on the independent NM test set[1]
Effect sizeRMSE of 1.41 ± 0.14 kcal/mol and PCC of 0.80 ± 0.06[1]
p-valuep values lower than 0.001[1]
Conflicts of interestNo conflict of interest[1]
Times cited83[1]

How iSEE compares across evaluation settings

The study says iSEE compared favorably with eight other predictors on an independent test set, while its broader blind-test assessment also found that it competed with established empirical-potential and machine-learning approaches.[1] [2]

What the results show-and do not show

The reported correlation indicates that predictions tended to track measured affinity changes in the evaluated sets; it does not mean that every individual mutation was predicted closely.[1]

Where iSEE's evidence is weakest

  • The authors note that limited experimental measurements make a small set of sensitive features important for generalization and robustness.[1]

What a broader test would need to resolve

  • How much do predictions change when the available experimental measurements are expanded, given the authors’ concern about data scarcity?[1]

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1002/prot.25630, Alternate LINK

Title: Isee: Interface Structure, Evolution, And Energy-Based Machine Learning Predictor Of Binding Affinity Changes Upon Mutations

Subject: Molecular Biology

Journal: Proteins: Structure, Function, and Bioinformatics

Publisher: Wiley

Authors: Cunliang Geng, Anna Vangone, Gert E. Folkers, Li C. Xue, Alexandre M. J. J. Bonvin

Published: 2018-12-03

Everything You Need To Know

1

What is iSEE and why is it important?

iSEE is a machine learning model designed to predict how mutations affect protein binding affinity. It uses a combination of structural, evolutionary, and energy-based features to achieve this. The model was trained on a large dataset of mutations and protein complexes, allowing it to make accurate predictions about changes in binding affinity. This is significant because understanding the impact of mutations on protein interactions is crucial for developing effective therapies and advancing personalized medicine.

2

What kind of information does iSEE use to predict the effects of mutations?

iSEE utilizes three key types of information: interface structure, evolution, and energy. Interface structure considers the 3D arrangement of the protein complex at the interaction site. Evolutionary information leverages the fact that conserved amino acids are often critical for protein function and binding. Energy calculations take into account factors like van der Waals forces and electrostatic interactions. By balancing these aspects, iSEE can accurately predict the impact of mutations.

3

How does iSEE compare to traditional methods of assessing protein binding affinities?

Computational approaches, including rigorous methods, empirical energy-based methods, and machine learning-based methods, offer a faster and more reliable alternative to experimental methods. iSEE falls into the machine learning category, which is gaining popularity due to its ability to analyze complex datasets and identify subtle patterns that influence protein interactions. iSEE's predictive capabilities can significantly accelerate research in drug discovery and personalized medicine.

4

How accurate is iSEE in predicting the effects of mutations on protein binding?

The accuracy of iSEE is measured by a Pearson correlation coefficient of 0.80 and a root mean square error of 1.41 kcal/mol. This level of accuracy is significant because it allows researchers to confidently use iSEE's predictions to guide their experiments and drug development efforts. The model's ability to accurately predict changes in binding affinity makes it a valuable tool for understanding the impact of mutations on protein interactions.

5

How can iSEE be used in drug discovery and personalized medicine?

iSEE can significantly impact drug discovery and personalized medicine by providing a faster, more reliable way to predict how mutations affect protein binding. This is crucial for developing effective therapies, especially for complex conditions like cancer. By understanding how mutations disrupt protein interactions, researchers can design drugs that specifically target these interactions and improve patient outcomes. Additionally, iSEE can help identify individuals who are more likely to respond to certain treatments based on their unique genetic makeup.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.